Why Adobe Is Trading Lower By 17%, Here Are 49 Stocks Moving In Thursday’s Mid-Day Session
Gainers
HeartBeam, Inc. (NASDAQ: BEAT) shares surged 58% to $1.96 after the company announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome and cardiac arrhythmia was issued by the USPTO.
Why Hill International Is Trading Higher By 15%; Here Are 30 Stocks Moving Premarket
Gainers
NewAge, Inc. (NASDAQ: NBEV) shares rose 19.7% to $0.2432 in pre-market trading. NewAge recently received Nasdaq notice on late filing of its form 10-Q.
Salarius Pharmaceuticals Adds Two Mayo Clinic Sites To Its Ongoing Phase 1/2 Trial Of Seclidemstat As A Treatment For Ewing’s Sarcoma And FET-Rearranged Sarcomas
Expands Trial to 17 U.S. Sites and 25 Locations
Initiation of All Anticipated U.S. Trial Sites Largely Completed
HOUSTON, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX), a
Salarius Pharmaceuticals: Q2 Earnings Insights
Salarius Pharmaceuticals (NASDAQ:SLRX) reported its Q2 earnings results on Friday, August 5, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings Scheduled For August 5, 2022
Companies Reporting Before The Bell
• Reservoir Media (NASDAQ:RSVR) is projected to report quarterly loss at $0.05 per share on revenue of $18.19 million.
Earnings Outlook For Salarius Pharmaceuticals
Salarius Pharmaceuticals (NASDAQ:SLRX) is set to give its latest quarterly earnings report on Friday, 2022-08-05. Here's what investors need to know before the announcement.
Analysts estimate that Salarius Pharmaceuticals will report an earnings per share (EPS) of $-0.10.
38 Stocks Moving In Thursday’s Mid-Day Session
Gainers
NeuroMetrix, Inc. (NASDAQ: NURO) shares climbed 34.6% to $4.1993 after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for reducing the symptoms of fibromyalgia.